Broder Schmidt and the Rohatgi and Brandman labs reveal that a major anti-cancer drug acts via disruption of nucleolar phase separation.
HomeStanford Biochemistry > News > Broder Schmidt and the Rohatgi and Brandman labs reveal that a major anti-cancer drug acts via disruption of nucleolar phase separation.
